Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9HBA0: Variant p.Glu797Lys

Transient receptor potential cation channel subfamily V member 4
Gene: TRPV4
Feedback?
Variant information Variant position: help 797 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 797 (E797K, p.Glu797Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In MTD and SMDK; also found in a patient with spondyloepiphyseal dysplasia Maroteaux type. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 797 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 871 The length of the canonical sequence.
Location on the sequence: help CFRVDEVNWSHWNQNLGIIN E DPGKNETYQYYGFSHTVGRL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         CFRVDEVNWSHWNQNLGIINEDPGKNETYQYYGFSHTVGRL

Mouse                         CFRVDEVNWSHWNQNLGIINEDPGKSEIYQYYGFSHTVGRL

Rat                           CFRVDEVNWSHWNQNLGIINEDPGKSEIYQYYGFSHTMGRL

Chicken                       CFRVDEVNWSHWNQNLGIISEDPGKSDTYQYYGFSHTVGRL
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 871 Transient receptor potential cation channel subfamily V member 4
Topological domain 723 – 871 Cytoplasmic
Modified residue 805 – 805 Phosphotyrosine
Beta strand 795 – 797



Literature citations
Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.
Camacho N.; Krakow D.; Johnykutty S.; Katzman P.J.; Pepkowitz S.; Vriens J.; Nilius B.; Boyce B.F.; Cohn D.H.;
Am. J. Med. Genet. A 152:1169-1177(2010)
Cited for: VARIANTS MTD ILE-89; ARG-197; PHE-331; PHE-471 DEL; MET-604; LEU-617; PRO-618; LYS-797 AND LEU-799; Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations.
Nishimura G.; Dai J.; Lausch E.; Unger S.; Megarbane A.; Kitoh H.; Kim O.H.; Cho T.J.; Bedeschi F.; Benedicenti F.; Mendoza-Londono R.; Silengo M.; Schmidt-Rimpler M.; Spranger J.; Zabel B.; Ikegawa S.; Superti-Furga A.;
Am. J. Med. Genet. A 152:1443-1449(2010)
Cited for: INVOLVEMENT IN SEDM; VARIANT PSTD HIS-594; VARIANTS LYS-183; CYS-602; LYS-797 AND LEU-799; Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family.
Dai J.; Kim O.H.; Cho T.J.; Schmidt-Rimpler M.; Tonoki H.; Takikawa K.; Haga N.; Miyoshi K.; Kitoh H.; Yoo W.J.; Choi I.H.; Song H.R.; Jin D.K.; Kim H.T.; Kamasaki H.; Bianchi P.; Grigelioniene G.; Nampoothiri S.; Minagawa M.; Miyagawa S.I.; Fukao T.; Marcelis C.; Jansweijer M.C.; Hennekam R.C.; Bedeschi F.; Mustonen A.; Jiang Q.; Ohashi H.; Furuichi T.; Unger S.; Zabel B.; Lausch E.; Superti-Furga A.; Nishimura G.; Ikegawa S.;
J. Med. Genet. 47:704-709(2010)
Cited for: VARIANTS MTD PHE-199; ALA-295; THR-331; PHE-342; PHE-471 DEL; LEU-592; LYS-775; ALA-799; SER-799; LEU-799 AND ARG-799; VARIANTS SMDK LYS-278; HIS-594; PRO-596; TRP-600; ILE-625; MET-709; TYR-777 AND LYS-797;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.